Content about Oncology

August 3, 2012

TV news station CBS Philly reports how Walgreen's Take Care Clinic nurse practitioner Renee Corradetti noticed an abnormality in a patient's throat, which later led to a diagnosis of an aggressive form of throat cancer.

TV news station CBS Philly reports how Walgreen's Take Care Clinic nurse practitioner Renee Corradetti noticed an abnormality in a patient's throat, which later led to a diagnosis of an aggressive form of throat cancer and life-saving chemotherapy treatments.

May 9, 2013

Cuts to Medicare payments due to the budget sequester have hit reimbursements for cancer drugs, according to a nonprofit group.

WASHINGTON — Cuts to Medicare payments due to the budget sequester have hit reimbursements for cancer drugs, according to a nonprofit group.

May 6, 2013

In recognition of "Melanoma Monday," L'Oréal Paris has released a new survey on melanoma awareness and prevention among women of all skin tones, and announced a philanthropic alliance with the Melanoma Research Alliance.

NEW YORK — In recognition of "Melanoma Monday," L'Oréal Paris has released a new survey on melanoma awareness and prevention among women of all skin tones, and announced a philanthropic alliance with the Melanoma Research Alliance.

April 26, 2013

More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.

WASHINGTON — More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.

The Pharmaceutical Research and Manufacturers of America said 241 medicines were in clinical development or under review by the Food and Drug Administration, including 98 for lymphoma, 97 for leukemia, 52 for multiple myeloma and 24 for malignancies of the bone marrow, blood and lymph nodes.

April 15, 2013

Vitamin D significantly reduces women's risks of developing uterine fibroids, according to a new study.

RESEARCH TRIANGLE PARK, N.C. — Vitamin D significantly reduces women's risks of developing uterine fibroids, according to a new study.

February 21, 2013

Less than one-quarter of American adults have ever had a skin check by a dermatologist despite rising rates of skin cancer, according to a new survey.

IRVINGTON, N.Y. — Less than one-quarter of American adults have ever had a skin check by a dermatologist despite rising rates of skin cancer, according to a new survey.

January 25, 2013

McKesson Specialty Health and the U.S. Oncology Network on Friday announced that Marcus Neubauer accepted the position of medical director of oncology services for McKesson Specialty Health, effective March 1.

THE WOODLANDS, Texas — McKesson Specialty Health and the U.S. Oncology Network on Friday announced that Marcus Neubauer accepted the position of medical director of oncology services for McKesson Specialty Health, effective March 1. 

January 4, 2013

Ahold banner Giant Food of Landover, Md., donated $37,305 to the Capital Breast Care Center.

LANDOVER, Md. — Ahold banner Giant Food of Landover, Md., donated $37,305 to the Capital Breast Care Center.

The donation, presented by Giant-Landover public and community relations manager Jamie Miller (center) to Capital Breast Care Center executive director Wanda Lucas (front row, second from right) comes from money collected by the chain during Breast Cancer Awareness Month.

December 28, 2012

Teva Pharmaceuticals has received approval of their new drug application for topotecan hydrochloride injection, a treatment for small cell lung cancer, according to Food and Drug Administration records.

SILVER SPRINGS, Md. — Teva Pharmaceuticals has received approval of their new drug application for topotecan hydrochloride injection, a treatment for small cell lung cancer, according to Food and Drug Administration records.

December 27, 2012

A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's Hospital.

MEMPHIS  — A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's Hospital.

The study found the estimated two-year cancer-free survival for patients enrolled in the study fell from 88% to 75% after the drug cyclophosphamide was substituted for mechlorethamine for treatment of patients with intermeidiate- or high-risk Hodgkin lymphoma. The study was launched before the drug shortages began.

December 14, 2012

The Food and Drug Administration has approved a new leukemia drug made by Ariad Pharmaceuticals, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new leukemia drug made by Ariad Pharmaceuticals, the agency said Friday.

The FDA announced the approval of Iclusig (ponatinib) to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, also known respectively as CML and Ph+ ALL.

November 20, 2012

Stop & Shop donated more than $250,000 to the American Cancer Society to support breast cancer research, education and awareness in October, the supermarket chain said Tuesday.

PURCHASE, N.Y. — Stop & Shop donated more than $250,000 to the American Cancer Society to support breast cancer research, education and awareness in October, the supermarket chain announced Tuesday.

October 26, 2012

A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.

BOUDRY, Switzerland — A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.

October 26, 2012

The Food and Drug Administration has approved what it called the second new drug in two months for a form of leukemia, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved what it called the second new drug in two months for a form of leukemia, the agency said Friday.

The FDA announced the approval of Teva Pharmaceutical Industries' Synribo (omacetaxine mepesuccinate) for chronic myelogenous leukemia, or CML, a disease that the National Institutes of Health expects will be diagnosed in more than 5,400 people this year. The drug is intended for patients whose disease has progressed after treatment with at least two drugs of a class used to treat the disease.

October 25, 2012

Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist.

 BIRMINGHAM, Ala. — Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist. In a study that appears in the same issue, researchers examined the use of aspirin in the treatment outcomes of patients with colorectal cancer.

October 24, 2012

Regional pharmacy chain Navarro Discount Pharmacy, which operates 31 locations in south Florida, is supplying pink prescription bottle caps on all prescriptions filled during the month of October in support of Breast Cancer Awareness month, the company has announced.

MIAMI and PEMBROKE PINES, Fla. — Regional pharmacy chain Navarro Discount Pharmacy, which operates 31 locations in south Florida, is supplying pink prescription bottle caps on all prescriptions filled during the month of October in support of Breast Cancer Awareness month, the company has announced.

“As a community pharmacy, we are focused on supporting activities that educate women, families and children about a variety of health issues,” stated Albert Garcia, EVP pharmacy operations at Navarro Discount Pharmacy.

October 12, 2012

Look Good Feel Better has announced the details of multiple new partnership programs being launched to support the Look Good Feel Better program during October’s Breast Cancer Awareness Month.

WASHINGTON — Look Good Feel Better has announced the details of multiple new partnership programs being launched to support the Look Good Feel Better program during October’s Breast Cancer Awareness Month.

Each partnership provides financial and/or educational support for the program and its mission to help people with cancer regain their appearance, sense of self and some normalcy while battling cancer.

October 12, 2012

The Food and Drug Administration has approved an injected drug for lung cancer made by Celgene, the company said Friday.

SUMMIT, N.J. — The Food and Drug Administration has approved an injected drug for lung cancer made by Celgene, the company said Friday.

Celgene announced the approval of Abraxane (paclitaxel) protein-bound particles for injectable suspension, for the first-line treatment of non-small cell lung cancer that has advanced locally or spread to other parts of the body, in combination with carboplatin, for patients who are not candidates for curative surgery or radiation therapy.

September 25, 2012

For the sixth consecutive year, Kroger has committed $3 million in donations for local breast cancer initiatives across the country to support National Breast Cancer Awareness month in October as part of its Giving Hope a Hand initiative.

CINCINNATI — For the sixth consecutive year, Kroger has committed $3 million in donations for local breast cancer initiatives across the country to support National Breast Cancer Awareness month in October as part of its Giving Hope a Hand initiative. 

September 19, 2012

Procter & Gamble Company and the National Breast Cancer Foundation have kicked off the fifth annual Give Hope program and its “Do It For the Girls!” campaign designed to rally women to take control of their breast health, take action and create an early detection plan in the fight against breast cancer.

CINCINNATI — Procter & Gamble Company and the National Breast Cancer Foundation have kicked off the fifth annual Give Hope program and its “Do It For the Girls!” campaign designed to rally women to take control of their breast health, take action and create an early detection plan in the fight against breast cancer.

September 11, 2012

Yoplait has kicked off its annual Save Lids to Save Lives breast cancer awareness campaign.

MINNEAPOLIS — Yoplait has kicked off its annual Save Lids to Save Lives breast cancer awareness campaign.

The yogurt brand said that as part of its campaign, the company once again has tapped actress and breast cancer survivor Adamari Lopez to join Yoplait's Save Lids to Save Lives Tour. The tour is making its way across the United States, stopping in U.S. cities with large Hispanic populations. The tour kicked off Sept. 6 in Miami and ends Oct. 26 in Houston. She will also visit New York, Chicago, Los Angeles, Dallas, Houston, San Antonio and Phoenix, Yoplait said.

September 11, 2012

Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

 SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

The Schaumburg, Ill.-based company announced the launch of ondansetron injection, used to prevent nausea and vomiting associated with emetogenic cancer chemotherapy and also to prevent nausea and vomiting that follows surgery.

Various versions of the drug had sales of $49 million during the 12-month period that ended in June, according to IMS Health.

September 5, 2012

The Food and Drug Administration has approved a new drug for treating a rare blood and marrow cancer that affects older adults, the agency said Tuesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare blood and marrow cancer that affects older adults, the agency said Tuesday.

The FDA announced the approval of Pfizer's Bosulif (bosutinib) for chronic myelogenous leukemia, or CML. According to the FDA, about 5,430 men and women will be diagnosed with CML this year.

The drug is designed for patients with chronic, accelerated or blast-phase Philadelphia chromosome-positive CML, who can't tolerate other therapies or for whom those therapies don't work.

August 30, 2012

Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.

DALLAS — Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.

May 3, 2012

Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

DEERFIELD, Ill. — Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.